Sustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous body
- PMID: 19834025
- DOI: 10.1167/iovs.09-4134
Sustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous body
Abstract
Purpose: Since 300-nm-mili apertures were present in the capsule of the foldable capsular vitreous body (FCVB), the authors tested whether the FCVB could mechanically release dexamethasone sodium phosphate (DexP) from its capsule.
Methods: In the in vitro study, DexP at concentrations of 0.25, 0.5, 1, 2, and 4 mg/mL in a balanced salt solution were injected into the capsules, which were immersed in cups of modified Franz diffusion cells. Two hundred microliters of liquid was aspirated at time intervals of 10, 20, 40, 60, 120, 180, 240, 300, and 360 minutes. In the in vivo study, the capsule was folded and implanted into the vitreous cavities of five rabbits. Approximately 0.6 mL DexP (2 mg/mL) was then injected into the capsule. An intravitreal injection with DexP was performed on another five rabbits as the control group. Aqueous humor was aspirated on days 1, 3, 7, 14, 28, and 42 after implantation. The DexP contents in the cups and aqueous humor were detected by HPLC-MS/MS.
Results: FCVB released DexP in a time-dependent and dose-dependent manner in vitro with five dosages from 10 to 360 minutes. Especially in the 0.25 mg/mL DexP group, the content (y) had good linear relationships with time (x), as shown by y = 0.7635x + 10.205. The DexP contents in the aqueous humor were detected until day 28 and were undetectable on day 42. However, the DexP contents were detected only before day 3 in the controls.
Conclusions: FCVB can sustainably and mechanically release DexP by capsule apertures in a time-dependent and dose-dependent manner in addition to serving as a vitreous substitute.
Similar articles
-
Evaluation of levofloxacin release characteristics from a human foldable capsular vitreous body in vitro.J Ocul Pharmacol Ther. 2012 Feb;28(1):33-40. doi: 10.1089/jop.2011.0109. Epub 2011 Oct 26. J Ocul Pharmacol Ther. 2012. PMID: 22029539
-
Evaluation of 5-fluorouracil released from a foldable capsular vitreous body in vitro and in vivo.Graefes Arch Clin Exp Ophthalmol. 2012 May;250(5):751-9. doi: 10.1007/s00417-011-1862-y. Epub 2011 Nov 27. Graefes Arch Clin Exp Ophthalmol. 2012. PMID: 22119880
-
A study of the dexamethasone sodium phosphate release properties from a periocular capsular drug delivery system.Drug Deliv. 2016;23(3):849-57. doi: 10.3109/10717544.2014.919543. Epub 2014 May 28. Drug Deliv. 2016. PMID: 24865291
-
Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous body.Int J Nanomedicine. 2012;7:1-10. doi: 10.2147/IJN.S25268. Epub 2011 Dec 30. Int J Nanomedicine. 2012. PMID: 22275817 Free PMC article.
-
A preliminary study to treat severe endophthalmitis via a foldable capsular vitreous body with sustained levofloxacin release in rabbits.Invest Ophthalmol Vis Sci. 2013 Jan 28;54(1):804-12. doi: 10.1167/iovs.12-9695. Invest Ophthalmol Vis Sci. 2013. PMID: 23258145
Cited by
-
Consensus on the Treatment of Severe Ocular Trauma and Silicone Oil-Dependent Eyes Using Foldable Capsular Vitreous Body.J Evid Based Med. 2025 Jun;18(2):e70041. doi: 10.1111/jebm.70041. J Evid Based Med. 2025. PMID: 40571677 Free PMC article.
-
A novel vitreous substitute of using a foldable capsular vitreous body injected with polyvinylalcohol hydrogel.Sci Rep. 2013;3:1838. doi: 10.1038/srep01838. Sci Rep. 2013. PMID: 23670585 Free PMC article.
-
Evaluation of supporting role of a foldable capsular vitreous body with magnetic resonance imaging in the treatment of severe retinal detachment in human eyes.Eye (Lond). 2011 Jun;25(6):794-802. doi: 10.1038/eye.2011.61. Epub 2011 Mar 18. Eye (Lond). 2011. PMID: 21423138 Free PMC article.
-
Three-Year Efficacy and Safety of a Silicone Oil-Filled Foldable-Capsular-Vitreous-Body in Three Cases of Severe Retinal Detachment.Transl Vis Sci Technol. 2016 Feb 1;5(1):2. doi: 10.1167/tvst.5.1.2. eCollection 2016 Jan. Transl Vis Sci Technol. 2016. PMID: 26855843 Free PMC article.
-
Protein kinase Cα downregulation via siRNA-PKCα released from foldable capsular vitreous body in cultured human retinal pigment epithelium cells.Int J Nanomedicine. 2011;6:1303-11. doi: 10.2147/IJN.S19405. Epub 2011 Jun 22. Int J Nanomedicine. 2011. PMID: 21753881 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical